IL-17A in LCH: Systemic Biomarker, Local Factor, or None of the Above?

Por Hogarty, Michael D
Publicado em 2011

Molecular Pathways: Disrupting polyamine homeostasis as a therapeutic strategy for neuroblastoma

Por Evageliou, Nicholas F., Hogarty, Michael D.
Publicado em 2009

Mutations in <it>PIK3CA </it>are infrequent in neuroblastoma

Por Mazanek Pavel, Morgan Brian T, Dam Vincent, Hogarty Michael D
Publicado em 2006-07-01

Mutations in PIK3CA are infrequent in neuroblastoma

Por Dam, Vincent, Morgan, Brian T, Mazanek, Pavel, Hogarty, Michael D
Publicado em 2006

The Stress Protein BAG3 Stabilizes Mcl-1 Protein and Promotes Survival of Cancer Cells and Resistance to Antagonist ABT-737

Por Boiani, Mariana, Daniel, Cristina, Liu, Xueyuan, Hogarty, Michael D., Marnett, Lawrence J.
Publicado em 2013

Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma

Por Bassiri, Hamid, Benavides, Adriana, Haber, Michelle, Gilmour, Susan K., Norris, Murray D., Hogarty, Michael D.
Publicado no Transl Pediatr (2015)

Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma

Por Gamble, Laura D., Hogarty, Michael D., Liu, Xueyuan, Ziegler, David S., Marshall, Glenn, Norris, Murray D., Haber, Michelle
Publicado em 2012

EGFR signaling defines Mcl(-)1 survival dependency in neuroblastoma

Por Nalluri, Srilatha, Peirce, Susan K, Tanos, Rachel, Abdella, Haneen A, Karmali, Dipan, Hogarty, Michael D, Goldsmith, Kelly C
Publicado no Cancer Biol Ther (2015)

BH3 Response Profiles From Neuroblastoma Mitochondria Predict Activity of Small Molecule Bcl-2 Family Antagonists

Por Goldsmith, Kelly C., Lestini, Brian J., Gross, Michelle, Ip, Laura, Bhumbla, Ashish, Zhang, Xuemei, Zhao, Huaqing, Liu, Xueyuan, Hogarty, Michael D.
Publicado em 2009

Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists

Por Lestini, Brian J., Goldsmith, Kelly C., Fluchel, Mark N., Liu, Xueyuan, Chen, Niel L., Goyal, Bella, Pawel, Bruce R., Hogarty, Michael D.
Publicado em 2009

Influence of Neuroblastoma Stage on Serum-Based Detection of MYCN Amplification

Por Combaret, Valerie, Hogarty, Michael D, London, Wendy B, McGrady, Patrick, Iacono, Isabelle, Brejon, Stephanie, Swerts, Katrien, Noguera, Rosa, Gross, Nicole, Rousseau, Raphael, Puisieux, Alain
Publicado em 2009

Mitochondrial Bcl-2 family dynamics define therapy response and resistance in neuroblastoma

Por Goldsmith, Kelly C., Gross, Michelle, Peirce, Susan, Luyindula, Dema, Liu, Xueyuan, Vu, Annette, Sliozberg, Michael, Guo, Rong, Zhao, Huaqing, Reynolds, C. Patrick, Hogarty, Michael D.
Publicado em 2012

A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma

Por Calabrese, Francesco Maria, Clima, Rosanna, Pignataro, Piero, Lasorsa, Vito Alessandro, Hogarty, Michael D., Castellano, Aurora, Conte, Massimo, Tonini, Gian Paolo, Iolascon, Achille, Gasparre, Giuseppe, Capasso, Mario
Publicado no Oncotarget (2016)

Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma

Por Yagyu, Shigeki, Iehara, Tomoko, Tanaka, Shiro, Gotoh, Takahiro, Misawa-Furihata, Akiko, Sugimoto, Tohru, London, Wendy B., Hogarty, Michael D., Teramukai, Satoshi, Nakagawara, Akira, Hiyama, Eiso, Maris, John M., Hosoi, Hajime
Publicado no PLoS One (2016)

ATF4 Regulates MYC-mediated Neuroblastoma Cell Death upon Glutamine Deprivation

Por Qing, Guoliang, Li, Bo, Vu, Annette, Skuli, Nicolas, Walton, Zandra E., Liu, Xueyuan, Mayes, Patrick A., Wise, David R., Thompson, Craig B., Maris, John M., Hogarty, Michael D., Simon, M. Celeste
Publicado em 2012

Clusterin, a Haploinsufficient Tumor Suppressor Gene in Neuroblastomas

Por Chayka, Olesya, Corvetta, Daisy, Dews, Michael, Caccamo, Alessandro E., Piotrowska, Izabela, Santilli, Giorgia, Gibson, Sian, Sebire, Neil J., Himoudi, Nourredine, Hogarty, Michael D., Anderson, John, Bettuzzi, Saverio, Thomas-Tikhonenko, Andrei, Sala, Arturo
Publicado em 2009

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

Por Sausen, Mark, Leary, Rebecca J., Jones, Siân, Wu, Jian, Reynolds, C. Patrick, Liu, Xueyuan, Blackford, Amanda, Parmigiani, Giovanni, Diaz, Luis A., Papadopoulos, Nickolas, Vogelstein, Bert, Kinzler, Kenneth W., Velculescu, Victor E., Hogarty, Michael D.
Publicado em 2012

Clinicopathological Characteristics of Ganglioneuroma and Ganglioneuroblastoma: A Report from the CCG and COG

Por Okamatsu, Chizuko, London, Wendy B., Naranjo, Arlene, Hogarty, Michael D., Gastier-Foster, Julie M., Look, A. Thomas, LaQuaglia, Michael, Maris, John M., Cohn, Susan L., Matthay, Katherine K., Seeger, Robert C., Saji, Tsutomu, Shimada, Hiroyuki
Publicado em 2009

Age-Dependent Prognostic Effect by Mitosis-Karyorrhexis Index in Neuroblastoma: A Report from the Children’s Oncology Group

Por Teshiba, Risa, Kawano, Shinya, Wang, Larry L., He, Lejian, Naranjo, Arlene, London, Wendy B., Seeger, Robert C., Gastier-Foster, Julie M., Look, A. Thomas, Hogarty, Michael D., Cohn, Susan L., Maris, John M., Park, Julie R., Shimada, Hiroyuki
Publicado no Pediatr Dev Pathol (2014)

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression

Por Lasorsa, Vito Alessandro, Formicola, Daniela, Pignataro, Piero, Cimmino, Flora, Calabrese, Francesco Maria, Mora, Jaume, Esposito, Maria Rosaria, Pantile, Marcella, Zanon, Carlo, De Mariano, Marilena, Longo, Luca, Hogarty, Michael D., de Torres, Carmen, Tonini, Gian Paolo, Iolascon, Achille, Capasso, Mario
Publicado no Oncotarget (2016)